Although experiments have also shown that myoblasts expressing VEGF165 up to 20-fold of basal level can be implanted into heart muscle damaged by myocardial infarction resulting in angiogenesis, improved circulation, and no hemangioma formation [54], the safety of VEGF overexpression therapy is still questioned [55]. Here, VEGFA is linked to myocardial infarction.